Colossal Biosciences Reports First Chick Hatch From Artificial Egg Technology

Colossal Biosciences says it has successfully hatched chicks using a fully artificial egg system designed to support bird embryo development outside a natural eggshell — a technology the company believes could aid future conservation and de-extinction efforts.
  • Colossal Biosciences successfully hatched chicks using an artificial egg platform.
  • The shell-less incubation system supports embryo development outside a natural egg.
  • Company says the technology could support endangered bird conservation and de-extinction research.
  • The platform was developed for large extinct bird species such as the South Island Giant Moa.
  • Researchers say the system may also have future applications in avian biotechnology and genome editing.

Colossal Biosciences announced it has successfully hatched live chicks using a fully artificial egg system designed to support complete bird embryo development outside a biological shell. The company described the technology as a major step for its avian conservation and de-extinction research programs.

According to Colossal, the artificial egg system recreates the oxygen exchange and developmental environment of a natural egg while allowing embryos to develop in a transparent, shell-free structure. Unlike earlier experimental systems, the company said the platform does not require supplemental oxygen and can operate in standard incubators.

Focus on Conservation and De-Extinction

Colossal said the technology is being developed in part to support its South Island Giant Moa de-extinction program, since no living bird species is large enough to serve as a surrogate for moa eggs.

Company leaders also said the artificial egg platform could have broader conservation applications for endangered bird species by helping support embryo development, genetic rescue efforts, and captive breeding programs.

“While we built this system to solve a specific de-extinction biological scale problem, the platform we created has implications well beyond de-extinction,” said Ben Lamm, CEO and co-founder of Colossal Biosciences, in the announcement.

Potential Biotechnology Applications

The company added that the platform may also support future avian biotechnology and genome-editing research by providing easier access to developing embryos during incubation. Researchers said the transparent design could improve monitoring and precision during embryo development and genetic engineering workflows.

Colossal Biosciences has focused heavily on developing technologies related to species restoration, conservation biology, and de-extinction initiatives using genetic engineering and reproductive biotechnology.

Information sourced from the Colossal Biosciences press release.

Never Miss an Animal Health Story

Sign up for free to receive the latest veterinary news, product announcements, and industry developments.